Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17266042

Int. J. Cancer 2007 May 1 120 9 1874-82

Download in:

View as

General Info

PMID
17266042